School mentorship programs in Irving, New York

The Academy for Excellence in Leadership is a prestigious secondary school located at 400 Irving Avenue in New York, United States. Our institution is dedicated to providing students with the skills, knowledge, and experiences necessary to become effective leaders in their communities and beyond. With a rigorous academic curriculum, a focus on character development, and opportunities for hands-on leadership training, our school prepares students to excel in their future endeavors. Join us at the Academy for Excellence in Leadership and embark on a transformative educational journey towards a successful and impactful leadership career.

Button Karla C is an educational institution located at 36 Thomas Indian School Drive in Irving, New York, United States. Our institution is committed to providing high-quality education and fostering a supportive learning environment for students of all ages. We offer a range of academic programs and extracurricular activities to help students reach their full potential. Our dedicated faculty and staff are passionate about helping students succeed and achieve their goals. Visit Button Karla C to discover a place where learning is engaging, inspiring, and transformative.

Barbara Pro, MD is a prestigious institution located at 161 Fort Washington Avenue in New York, United States. Dr. Barbara Pro is a highly respected clinician, researcher, and professor of medicine at Columbia University Vagelos College of Physicians and Surgeons, specializing in Hematology and Oncology. As the clinical director of the lymphoma program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia, Dr. Pro leads a dedicated team of experts focused on developing innovative treatments for patients with lymphoma. Dr. Pro's expertise lies in T-cell lymphoma, a rare form of non-Hodgkin lymphoma. She is renowned for her work in drug development for both Hodgkin and non-Hodgkin lymphomas, leading multi-center clinical trials to evaluate new targeted therapies for aggressive lymphoma subtypes. Her research has resulted in FDA approvals of novel agents, benefiting patients worldwide.